Literature DB >> 3294069

Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse.

S Reddy1, N J Bibby, R B Elliott.   

Abstract

The predictive value of insulitis, islet cell cytoplasmic antibodies and insulin autoantibodies for insulin-dependent diabetes was studied in young female non-obese diabetic mice. The ontogeny of the three markers was examined cross-sectionally at days 15, 25, 40 and 90 while islet cell antibodies and insulin autoantibodies were studied longitudinally from day 35 or day 144-168 until approximately day 250. Insulitis was first observed at day 40 (50%) and subsequently at day 90 (70%). Islet cell antibodies and insulin autoantibodies were present at day 15 in 46% and 54% of the animals respectively. The rate of islet cell antibodies was slightly higher at day 25 (60%) than at day 40 (40%) and day 90 (54%) whereas antibodies to insulin were present in all samples from day 25-90. At day 40 and day 90 insulitis and insulin autoantibodies were present together in 42% and 70% of the animals, respectively, while insulitis and islet cell antibodies had a lower rate of concordance (17% and 42%, respectively; diabetes rate, 30%). The concordance rates for islet cell antibodies and insulin autoantibodies were 42% at day 40 and 54% at day 90. Concordance for all three markers was first observed at day 40 (17%) which increased to 38% at day 90. In longitudinal studies, islet cell antibodies and insulin autoantibodies were often present together whether or not diabetes supervened. In the islet cell antibody procedure, immunoreactive cells were shown immunohistochemically to correspond with insulin and/or glucagon cells. However, this staining was not suppressible with insulin- or glucagon- absorbed sera, implying the presence of non-hormonal autoantigens. We conclude that the three markers investigated are expressed early after birth and well before clinical symptoms appear in this animal model. Both islet cell antibodies and insulin autoantibodies preceded insulitis but the prevalence rate for each marker or their degree of concordance was different from the anticipated rate of diabetes in our colony. Consequently, the early expression of the three markers alone is not predictive of diabetes although concordance for the two, or all three markers may be of some value. However, no animal developed diabetes without the prior appearance of both islet cell antibodies and insulin autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294069     DOI: 10.1007/bf00277415

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  22 in total

1.  "Cytoplasmic" islet cell antibodies. Evidence that the target antigen is a sialoglycoconjugate.

Authors:  R C Nayak; M A Omar; A Rabizadeh; S Srikanta; G S Eisenbarth
Journal:  Diabetes       Date:  1985-06       Impact factor: 9.461

2.  The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome.

Authors:  A F Nakhooda; A A Like; C I Chappel; C N Wei; E B Marliss
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

3.  A micro enzyme-linked immunosorbent assay for insulin antibodies in serum.

Authors:  T Wilkin; S Nicholson; C Casey
Journal:  J Immunol Methods       Date:  1985-01-21       Impact factor: 2.303

4.  A beta-cell glycoprotein of Mr 40 000 is the major rat islet cell immunogen following xenogenic immunisation.

Authors:  S Baekkeskov; A Lernmark
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

5.  Production of monoclonal antibodies to islet cell surface antigens using hybridization of spleen lymphocytes from non-obese diabetic mice.

Authors:  K Yokono; K Shii; J Hari; S Yaso; Y Imamura; K Ejiri; K Ishihara; S Fujii; T Kazumi; H Taniguchi
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

6.  Defect of the first-phase insulin secretion to glucose stimulation in the perfused pancreas of the nonobese diabetic (NOD) mouse.

Authors:  Y Kano; T Kanatsuna; N Nakamura; Y Kitagawa; H Mori; S Kajiyama; K Nakano; M Kondo
Journal:  Diabetes       Date:  1986-04       Impact factor: 9.461

7.  Dietary prevention of diabetes in the non-obese diabetic mouse.

Authors:  R B Elliott; S N Reddy; N J Bibby; K Kida
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

8.  Application of a rapid enzyme-linked immunosorbent microassay (ELISA) to study human anti-insulin antibody.

Authors:  L J Nell; V J Virta; J W Thomas
Journal:  Diabetes       Date:  1985-01       Impact factor: 9.461

9.  Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat.

Authors:  T Dyrberg; A F Nakhooda; S Baekkeskov; A Lernmark; P Poussier; E B Marliss
Journal:  Diabetes       Date:  1982-03       Impact factor: 9.461

10.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01
View more
  16 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

3.  Lack of expression of antigens for islet cell antibodies in rat fetal pancreas.

Authors:  Y Yamashiro; H Taniguchi; S Baba; T Taniguchi; S Kodama; S Aono; G Isshiki; T Jinnouchi
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

4.  Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study.

Authors:  Shiva Reddy; Praneeti Pathipati; Yan Bai; Elizabeth Robinson; Jacqueline M Ross
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

5.  Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products.

Authors:  C Boitard; M C Villa; C Becourt; H P Gia; C Huc; P Sempe; M M Portier; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

Review 6.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

7.  Insulin as a target antigen in autoimmune diabetes: a natural repertoire as the source of antibody response.

Authors:  K G Petersen; A N Khalaf; V Naithani; M Fabry; H Gattner
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

Review 8.  The role of the intestinal microbiota in type 1 diabetes mellitus.

Authors:  Mikael Knip; Heli Siljander
Journal:  Nat Rev Endocrinol       Date:  2016-01-04       Impact factor: 43.330

9.  Immunohistochemical demonstration of leptin in pancreatic islets of non-obese diabetic and CD-1 mice: co-localization in glucagon cells and its attenuation at the onset of diabetes.

Authors:  S Reddy; E M Lau; J M Ross
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

10.  Presence of residual beta cells and co-existing islet autoimmunity in the NOD mouse during longstanding diabetes: a combined histochemical and immunohistochemical study.

Authors:  Shiva Reddy; Ryan Chau Chia Chai; Jessica Astrid Rodrigues; Tzu-Hsuan Hsu; Elizabeth Robinson
Journal:  J Mol Histol       Date:  2007-09-22       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.